PREVENTION OF VENTRICULAR FIBRILLATION DURING ACUTE MYOCARDIAL INFARCTION BY INTRAVENOUS PROPRANOLOL
- 20 October 1984
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 324 (8408), 883-886
- https://doi.org/10.1016/s0140-6736(84)90651-2
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Reduction of Infarct Size with the Early Use of Timolol in Acute Myocardial InfarctionThe New England Journal of Medicine, 1984
- Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarctionThe American Journal of Cardiology, 1983
- Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.Heart, 1981
- EARLY INTRAVENOUS ATENOLOL TREATMENT IN SUSPECTED ACUTE MYOCARDIAL INFARCTION: Preliminary Report of a Randomised TrialThe Lancet, 1980
- Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts.Heart, 1980
- PROTECTIVE EFFECT OF PROPRANOLOL IN THREATENED MYOCARDIAL INFARCTIONThe Lancet, 1978
- Reduction of enzyme levels by propranolol after acute myocardial infarction.Circulation, 1978
- Protective effect of beta adrenoceptor blockade in experimental coronary occlusion in conscious dogsThe American Journal of Cardiology, 1972
- Propranolol in the prevention of ventricular fibrillation due to experimental coronary artery occlusion: Observations on its mode of actionThe American Journal of Cardiology, 1967
- Beta-adrenergic blockade in experimental myocardial infarctionAmerican Heart Journal, 1966